Citrini Bets on Life Sciences After Claude AI Drug Study

Citrini Research highlights the potential benefits for life sciences companies from AI-driven drug discovery after evaluating Anthropic PBC's Claude Science model. The study underscores AI's growing role in advancing pharmaceutical research.